Cargando…
PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma
Abnormal proline-rich protein 11 (PRR11) expression is associated with various tumors. However, there are few reports concerning PRR11 with prognostic risk, immune infiltration, or immunotherapy of bladder urothelial carcinoma (BLCA). This study is based on online databases, such as Oncomine, GEPIA,...
Autores principales: | Ni, Wenpeng, Yi, Lijuan, Dong, Xiaoru, Cao, Mengjie, Zheng, Jinjuan, Wei, Qingling, Yuan, Chunlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899238/ https://www.ncbi.nlm.nih.gov/pubmed/36739300 http://dx.doi.org/10.1038/s41598-023-29316-2 |
Ejemplares similares
-
KDELR2 as a diagnostic and prognostic biomarker of bladder urothelial carcinoma and its correlation with immune infiltration
por: Ma, Sai, et al.
Publicado: (2023) -
PRR7-AS1 Correlates with Immune Cell Infiltration and Is a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Lu, Yifan, et al.
Publicado: (2022) -
The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma
por: Chen, Ying, et al.
Publicado: (2015) -
PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer
por: Song, Zongchang, et al.
Publicado: (2015) -
Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma
por: Guo, Ya, et al.
Publicado: (2022)